UNIVERSITY OF FLORIDA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1853-01-01

Employees: 10K

Market Cap: -

Website: http://www.ufl.edu

Clinical Trials

Beat AML Core Study

Completed

Conditions: Acute Myeloid Leukemia

First Posted Date: 2016-10-06

Last Posted Date: 2020-08-05

Lead Sponsor: University of Florida

Target Recruit Count: 22

Registration Number: NCT02927106

Locations: 🇺🇸
UF Health Cancer Center, Gainesville, Florida, United States

TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003)

Phase 2

Terminated

Conditions: Pancreatic Cancer

Interventions: Drug: TAS-102

First Posted Date: 2016-10-03

Last Posted Date: 2021-02-04

Lead Sponsor: University of Florida

Target Recruit Count: 7

Registration Number: NCT02921737

Locations: 🇺🇸
UF Health Cancer Center, Gainesville, Florida, United States
🇺🇸
Tallahasee Memorial HealthCare, Tallahassee, Florida, United States
🇺🇸
Malcom Randall VA Medical Center, Gainesville, Florida, United States

Management of Uncontrolled Hypertension (HTN)

Not Applicable

Terminated

Conditions: Hypertension

Interventions: Device: Ambulatory blood pressure monitor (ABPM)
Other: Chronotherapy

First Posted Date: 2016-10-03

Last Posted Date: 2022-12-02

Lead Sponsor: University of Florida

Target Recruit Count: 2

Registration Number: NCT02922023

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

TAS-102 in Previously Treated Unresectable or Metastatic Squamous Cell Lung Carcinoma (UF-STO-LUNG-003)

Phase 2

Completed

Conditions: Squamous Cell Lung Carcinoma

Interventions: Drug: TAS-102

First Posted Date: 2016-09-30

Last Posted Date: 2022-06-23

Lead Sponsor: University of Florida

Target Recruit Count: 4

Registration Number: NCT02920476

Locations: 🇺🇸
UF Health Cancer Center, Gainesville, Florida, United States

Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002)

Phase 1

Terminated

Conditions: Non-Small Cell Lung Cancer

Interventions: Drug: Gedatolisib
Drug: Paclitaxel
Drug: Carboplatin

First Posted Date: 2016-09-30

Last Posted Date: 2019-10-04

Lead Sponsor: University of Florida

Target Recruit Count: 3

Registration Number: NCT02920450

Locations: 🇺🇸
UF Health Cancer Center, Gainesville, Florida, United States

Additive Benefit of the Urine LAM Test to Current TB Diagnostics in HIV Positive Adults in Panama City, Panama

Not Applicable

Withdrawn

Conditions: Histoplasmosis
Tuberculosis
HIV

Interventions: Other: Urine LAM Ag test

First Posted Date: 2016-09-22

Last Posted Date: 2017-12-26

Lead Sponsor: University of Florida

Registration Number: NCT02911740

Cardiovascular Health of Older Adults and Resveratrol (CORE)

Completed

Conditions: Aging

Interventions: Other: Observation

First Posted Date: 2016-09-21

Last Posted Date: 2018-11-29

Lead Sponsor: University of Florida

Target Recruit Count: 27

Registration Number: NCT02909699

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Topical NanoDox® for Atopic Dermatitis

Phase 2

Completed

Conditions: Dermatitis, Atopic

Interventions: Drug: Nanodox 1% (doxycycline monohydrate hydrogel)

First Posted Date: 2016-09-21

Last Posted Date: 2020-03-26

Lead Sponsor: University of Florida

Target Recruit Count: 23

Registration Number: NCT02910011

Locations: 🇺🇸
UF Health Springhill, Gainesville, Florida, United States
🇺🇸
UF HealthStreet, Gainesville, Florida, United States

PEAKS: Validation of Mobile Technologies

Completed

Conditions: Exercise
Fitness Trackers
Health Services for Persons With Disabilities
Disability Evaluation
Validation Studies

First Posted Date: 2016-09-05

Last Posted Date: 2019-05-13

Lead Sponsor: University of Florida

Target Recruit Count: 113

Registration Number: NCT02888483

Locations: 🇺🇸
UF Institute on Aging Clinical and Translational Research Building, Gainesville, Florida, United States

Physiologic Effects of Topiramate on Cognition

Phase 1

Completed

Conditions: Alteration of Cognitive Function

Interventions: Drug: Placebo
Drug: Topiramate

First Posted Date: 2016-08-30

Last Posted Date: 2017-01-11

Lead Sponsor: University of Florida

Target Recruit Count: 11

Registration Number: NCT02884050

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy